Literature DB >> 11058877

Polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population.

H Shen1, Y Xu, Y Qian, R Yu, Y Qin, L Zhou, X Wang, M R Spitz, Q Wei.   

Abstract

Gastric cancer remains the leading cause of cancer death in China and other countries in eastern Asia. Studies of gastric cancer have revealed that it is a disease of complex etiology involving dietary, infectious, environmental, occupational and genetic factors. DNA repair capacity has been suggested as a genetic factor contributing to variation in susceptibility to cancer. In the present study, we described an association between 2 polymorphisms of the DNA repair gene XRCC1 and risk of gastric cancer in a Chinese population. We used a polymerase chain reaction-based assay to detect Pvu II and Nci I restriction fragment length polymorphisms (XRCC1 26304 C-->T and XRCC1 28152 G-->A, respectively) in 188 patients with gastric cancer and 166 healthy controls. The XRCC1 26304 T allele (194Trp) frequency (34.6%) was higher and the XRCC1 28152 A allele (399Gln) frequency (25.6%) was lower in healthy Chinese controls than previously reported healthy U.S. Caucasian controls (7.2% and 34.1%, respectively). Multivariate logistic regression analysis revealed that the putative high-risk genotypes XRCC1 26304 CC and XRCC1 28152 GA/AA were associated with a non-significant increased risk for gastric cancer (adjusted odds ratio [OR]=1.45, 95% confidence interval [CI]= 0.93-2.25 and OR=1.53, 95% CI= 0.98-2.39, respectively) compared with other genotypes. However, the XRCC1 26304 CC genotype was associated with a significantly increased risk for gastric cardia cancer (adjusted OR=1.86, 95% CI=1.09-3.20). Individuals with both putative high-risk genotypes (CC and GA/AA) had a significantly higher risk (adjusted OR=1.73, 95% CI=1.12-2.69), particularly for gastric cardia cancer (adjusted OR=2.18, 95% CI=1.21-3.94) than individuals with other genotypes. These findings support the hypothesis that these 2 XRCC1 variants may contribute to the risk of developing gastric cancer, particularly gastric cardia cancer. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11058877     DOI: 10.1002/1097-0215(20001115)88:4<601::aid-ijc13>3.0.co;2-c

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  47 in total

1.  A functional variant at the miR-184 binding site in TNFAIP2 and risk of squamous cell carcinoma of the head and neck.

Authors:  Zhensheng Liu; Sheng Wei; Hongxia Ma; Mei Zhao; Jeffrey N Myers; Randal S Weber; Erich M Sturgis; Qingyi Wei
Journal:  Carcinogenesis       Date:  2011-09-20       Impact factor: 4.944

2.  Association between polymorphisms in APE1 and XRCC1 and the risk of gastric cancer in Korean population.

Authors:  Eun-Heui Jin; JaeWoo Kim; Sang-Il Lee; Jang Hee Hong
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  The Arg194Trp polymorphism in the XRCC1 gene and cancer risk in Chinese Mainland population: a meta-analysis.

Authors:  Jin Huang; Jie Zhang; Yuliang Zhao; Banghua Liao; Jiaming Liu; Ling Li; Mingheng Liao; Lanlan Wang
Journal:  Mol Biol Rep       Date:  2011-04-16       Impact factor: 2.316

4.  CDH1 gene polymorphisms, plasma CDH1 levels and risk of gastric cancer in a Chinese population.

Authors:  Zhen Zhan; Juan Wu; Jun-Feng Zhang; Ya-Ping Yang; Shujuan Tong; Chun-Bing Zhang; Jin Li; Xue-Wen Yang; Wei Dong
Journal:  Mol Biol Rep       Date:  2012-04-26       Impact factor: 2.316

5.  Characterization of Gastric Cardia Tumors: Differences in Helicobacter pylori Strains and Genetic Polymorphisms.

Authors:  Débora Menezes da Costa; Eliane Dos Santos Pereira; Isabelle Joyce de Lima Silva-Fernandes; Márcia Valéria Pitombeira Ferreira; Silvia Helena Barem Rabenhorst
Journal:  Dig Dis Sci       Date:  2015-04-24       Impact factor: 3.199

6.  Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.

Authors:  Yan-Zhong Feng; Yi-Ling Liu; Xiao-Feng He; Wu Wei; Xu-Liang Shen; Dao-Lin Xie
Journal:  Tumour Biol       Date:  2014-07-27

7.  Genetic Polymorphisms of X-ray Repair Cross-Complementing Group 1 and Apurinic/Apyrimidinic Endonuclease-1 in Chronic Obstructive Pulmonary Disease.

Authors:  Avinash Bardia; Sandeep Kumar Vishwakarma; Chandrakala Lakki Reddy; N Raju; Shaik Iqbal; Gallapalli Sravani; Narneni Lavanya; Nazima Begum; Naziya Usma; Pratibha Nallari; Syed Mehmood Ahmed; Asfaq Hasan; Aleem A Khan
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

8.  Genetic variations in XRCC1 gene in sporadic head and neck cancer (HNC) patients.

Authors:  Ishrat Mahjabeen; Ruqia Mehmood Baig; Nosheen Masood; Maimoona Sabir; Uzma Inayat; Faraz Arshad Malik; Mahmood Akhtar Kayani
Journal:  Pathol Oncol Res       Date:  2012-09-29       Impact factor: 3.201

Review 9.  Pharmacogenomics in colorectal cancer: the first step for individualized-therapy.

Authors:  Eva Bandrés; Ruth Zárate; Natalia Ramirez; Ana Abajo; Nerea Bitarte; Jesus Garíia-Foncillas
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

10.  Molecular epidemiology of genetic susceptibility to gastric cancer: focus on single nucleotide polymorphisms in gastric carcinogenesis.

Authors:  Ming Yin; Zhibin Hu; Dongfeng Tan; Jaffer A Ajani; Qingyi Wei
Journal:  Am J Transl Res       Date:  2009-01-01       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.